期刊文献+

FDG PET评价结直肠癌术后复发及转移的价值 被引量:10

FDG PET in assessment of recurrent colorectum cancer post-operation and metastasis
下载PDF
导出
摘要 目的评价FDGPET对结直肠癌术后复发及转移的价值。方法51例结直肠癌术后患者行FDGPET显像,并与CT及血清CEA结果进行比较。结果FDGPET诊断结直肠癌术后复发的灵敏度、特异性、准确性分别为94.3%、93.8%、94.1%;CT结果为84.4%、57.9%、74.5%;血清CEA结果为57.9%、85.7%、65.4%。51例患者中FDGPET显像发现29例肝脏转移,灵敏度为100%,CT诊断肝转移21例,灵敏度为72.4%。结论FDGPET显像评价结直肠癌术后复发与转移明显优于CT及血清CEA。 Objective To evaluate the value of FDG PET in recurrence and metastasis of colorectum cancer post-operation. Methods FDG PET imaging were performed for 51 post-operation colorectum cancer patients, and compared with CT scans and serum tumor marker CEA. Results The sensitivity, specificity and accuracy of FDG PET were 94.3%, 93.8% and 94.1 %, for CT were 84.4 %, 57.9 %, 74.5 %, and for CEA were .57.9 %, 85.7 %, 65.4 % respectively. PET also found 29 liver metastasis, CT found 21 metastasis, the sensitivity of PET and CT were 100% and 72.4% respectively. Conclusion FDG PET is superior to CT and CEA in diagnosis of recurrent and metastasis colorectum cancer post-operation.
出处 《中国医学影像技术》 CSCD 北大核心 2005年第9期1434-1436,共3页 Chinese Journal of Medical Imaging Technology
关键词 结直肠癌 复发 ^18F-脱氧葡萄糖 体层摄影术 发射型计算机 正电子 Colorectum cancer Recurrence ^18F-fluorodeoxyglucose Tomography, emission-computed, positron
  • 相关文献

参考文献9

二级参考文献38

  • 1王辉,陈民钧,徐英春.简要介绍美国NCCLS药敏试验纸片扩散法法规(续)(1994年12月版)[J].中华医学检验杂志,1995,18(2):118-124. 被引量:136
  • 2Blasberg RG.Prediction of brain tumor therapy response by PET[J].J Neurooncol, 1994,22(3):281-286.
  • 3Wong TZ, van der Westhuizen G, Coleman RE. Positron emission tomography imaging of brain tumors[J]. Neuroimaging Clin N Am,2002,12(4):615-626.
  • 4Nestle U, Walter K, Schmi-dt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis[J].Int J Radiation Oncology Biol Phys,1999,44(3):593-597.
  • 5Chao ST, Suh JH, Raja S,et al.The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery[J]. Int J Cancer, 2001,96(3):191-197.
  • 6Yamamoto Y, Nishiyama Y, Toyama Y,et al. 99Tcm-MIBI and 201Tl SPET in the detection of recurrent brain tumours after radiation therapy[J]. Nucl Med Commun, 2002,23(12):1183-1190.
  • 7Buchpiguel CA, Alavi JB, Alavi A, et al. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain[J]. J Nucl Med,1995,36(1):159-164.
  • 8Glantz MJ, Hoffman JM, Coleman RE, et al. Identification of early recurrence of primary central nervous system tumors by [18F] fluorodeoxyglucose positron emission tomography[J]. Ann Neurol, 1991,29(4):347-355.
  • 9Ogawa T, Inugami A, Hatazawa J, et al. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F-18 and L-Methyl-11C-methionine[J]. AJNR,1996,17(2):345-353.
  • 10Chung JK,Kim YK,Kim SK,et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 18F-FDG PET[J]. Eur J Nucl Med Mol Imaging,2002,29(2):176-182.

共引文献21

同被引文献116

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部